Stanker James H - Insider Non-Derivative Transactions at Processa Pharmaceuticals, Inc. (PCSA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jul 10, 2024, Stanker James H's relationship to Processa Pharmaceuticals, Inc. (PCSA) is Officer (Chief Financial Officer), and currently has 6,764 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other PCSA insiders.
Data Source: SEC.
Stanker James H - Insider Non-Derivative Transactions of PCSA Common Stock
Stanker James H - Insider Non-Derivative Transactions at PCSA
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jul 11, 2024 | F -- (Common Stock) | 282 | 1.71 | 6482 |
| Jul 11, 2024 | M -- (Common Stock) | 644 | 0 | 6764 |
| Apr 6, 2024 | F -- (Common Stock) | 518 | 2.79 | 6120 |
| Apr 6, 2024 | M -- (Common Stock) | 1675 | 0 | 6638 |
| Jan 2, 2024 | F -- (Common Stock) | 518 | 2.79 | 6120 |
| Jan 2, 2024 | M -- (Common Stock) | 1675 | 0 | 6638 |
| Oct 13, 2023 | Acquisition -- (Common Stock) | 15000 | 0.33 | 99250 |
| Oct 11, 2023 | Acquisition -- (Common Stock) | 22500 | 0.24 | 84250 |
| Feb 10, 2023 | Acquisition -- (Common Stock) | 12500 | 0.8 | 61750 |